Dry Powder Nasal Delivery of Emergency Use Medications
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
Belhaven Biopharma, Inc.
Award Date
Award Amount
500,000
Program Name
Strategic Growth Loan
Program Category
Business Financing
Principal Investigator
Scott Lyman
Fiscal Year
2023
Region
Research Triangle
Project Description:
Belhaven Pharmaceuticals is developing a dry powder intranasal epinephrine for the treatment of anaphylaxis. The SGL funds will be used for clinical trial material scale-up and production, IND preparation and filing, and a pilot human clinical trial.